VRX Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) Investors
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: PR Newswire
BOSTON, March 30, 2020 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) that it is filing legal claims against the company on behalf of investors.The company has recently agreed to settle a shareholder lawsuit filed against it by investors for over $1.2 billion dollars.Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) investors that purchased between January 4, 2013 and March 15, 2016 are urged to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit Settlement website or call 1-800-934-2921 to speak to someone about your case. Your legal rights will be affected whether you act or do not act. If you do not act, you may permanently forfeit your right to recover on this claim.The shareholder lawsuit stemmed from investor's allegations of US securities law violations committed by Valeant Pharmaceuticals Intl (NYSE:VRX) management that led to signific
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch & Lomb Corporation (BLCO)-A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis [Yahoo! Finance]Yahoo! Finance
- PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS [Yahoo! Finance]Yahoo! Finance
- Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of CirrhosisAccesswire
- PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSSAccesswire
BHC
Earnings
- 10/30/24 - Miss
BHC
Sec Filings
- 11/1/24 - Form 8-K
- 10/31/24 - Form 10-Q
- 10/30/24 - Form 8-K
- BHC's page on the SEC website